A review of 19 double-blind placebo-controlled studies in social anxiety disorder (Social Phobia)

World Journal of Biological Psychiatry

Volumn 1, Issue 1, 2000, Pages 27-33

  Versiani, Marcio ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

clonazepam; double blind; drug treatment; fluvoxamine; moclobemide; paroxetine; phenelzine; placebocontrolled; review; sertraline; Social Phobia

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR;

CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; HUMAN; PHOBIA; REVIEW;

CALCIUM CHANNEL BLOCKERS; CONTROLLED CLINICAL TRIALS; DOUBLE-BLIND METHOD; HUMANS; MONOAMINE OXIDASE INHIBITORS; PHOBIC DISORDERS; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0033993390     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970009150563     Document Type: Article

References (23)

1. Anon, The International Multicenter Clinical Trial Croup on Moclobemide in Social Phobia (1997) Moclobemide in social phobia. A double-blind, placebo-controlled clinical study.
2. Baldwin D, Bobes J, Stein DJ, Scharwachter I, Faure M (1999) Paroxetine in social phobia/social anxiety disorder. Brit J Psychiatry 175:120-126.
3. Davidson JR, Potts N, Richichi E, Krishnan R, Ford SM, Smith R, Wilson WH (1993) Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 13:423-428.
4. Fahlen T, Nilsson HL, Borg K, Humble M, Pauli U (1995) Social phobia: the clinical efficacy and tolerability of the monoamine oxidase-a and serotonin uptake inhibitor brofaromine. A doubleblind placebo-controlled study. Acta Psychiatr Scand 92:351-358.
5. Heimberg RC, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz LA, Juster HR, Campeas R, Bruch MA, Cloitre M, Fallon B, Klein DF (1998) Cognitive behavioral group therapy vs. phenelzine therapy for social phobia: 12-week outcome. Arch Cen Psychiatry 55:1133-1141.
6. Katzelnick DI, Kobak KA, Creist JH, Jefferson JW, Mantle JM, Serlin RC (1995) Sertraline for social phobia: a double-blind, placebocontrolled crossover study. Am J Psychiatry 152:1368-1371.
7. Liebowitz MR, Quitkin FM, Stewart JW, McCrath PJ, Harrison W, Rabkin J, Tricamo E, Markowitz JS, Klein DF (1984) Phenelzine v imipramine in a.typical depression. A preliminary report. Arch Cen Psychiatry 41:669-77
8. Liebowitz MR, Gorman JM, Fyer AJ, Klein DF (1985) Social phobia, review of a neglected anxiety disorder. Arch Cen Psychiatry 42:729-736.
9. Liebowitz MR, Fyer AJ, Gorman JM, Campeas R, Levin A (1986) Phenelzine in social phobia. J Clin Psychopharmacol 6:93-98.
10. Liebowitz MR, Schneier F, Campeas R, Hollander E, Hatterer J, Fyer A, Gorman J, Papp L, Davies S, Gully R (1992) Phenelzine vs.atenolol in social phobia. A placebo-controlled comparison. Arch Gen Psychiatry 49:290-300.
11. Lott M, Greist JH, Jefferson JW, Kobak KA, Katzelnick Dj, Katz RJ, Schaettle SC (1997) Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study. J Clin Psychopharmacol 1 7:255-260.
12. Noyes R Jr, Moroz C, Davidson JR, Liebowitz MR, Davidson A, Siegel J, Bell J, Cain JW, Curlik SM, Kent TA, Lydiard RB, Mallinger AG, Pollack MH, Rapaport M, Rasmussen SA, Hedges D, Schweizer E, Uhlenhuth EH (1997) Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacol 17:247-254.
13. Gelernter CS, Uhde TW, Cimbolic P, Arnkoff DB, Vittone BJ, Tancer ME, Bartko JJ (1991) Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. Arch Cen Psychiatry 48:938-945.
14. Pande AC, Davidson JR, Jefferson JW, Janney CA, Katzelnick DJ, Weisler RH, Greist JH, Sutherland SM (1999) Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 19:341-8.
15. Schneier FR, Goetz D, Campeas R, Fallon B, Marshall R, Liebowitz MR (1998) Placebo-controlled trial of moclobemide in social phobia. Br J Psychiatry 172:70-77.
16. Stein MB, Liebowitz MR, Lydiard RB, Pitts CD, Bushnell W, Gergel I (1998) Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial. JAMA 280:708-713.
17. Stein MB, Fyer AJ, Davidson JR, Pollack MH, Wiita B (1999) Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. Am J Psychiatry 156:756-760.
18. van Vliet IM, Den Boer JA, Westenberg HG (1992) Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective mao-a inhibitor. Eur Neuropsychopharmacol 2:21-29.
19. van Vliet IM, Den Boer JA, Westenberg HG (1994) Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine. Psychopharmacology (Berl) 115:128-134.
20. van Vliet IM, Den Boer JA, Westenberg HC, Pian KL (1997) Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study. J Clin Psychiatry 58:164-168.
21. Versiani M, Mundim FD, Nardi AE, Liebowitz MR (1988) Tranylcypromine in social phobia. J Clin Psychopharmacol 8:279-283.
22. Versiani M, Nardi AE, Mundim FD, Alves AB, Liebowitz MR, Amrein R (1992) Pharmacotherapy of social phobia, a controlled study with moclobemide and phenelzine. Br J Psychiatry 161:353-360.
23. Versiani M, Nardi AE, Figueira I, Marques C (1997) Double-blind placebo controlled trial with bromazepam in social phobia. J. bras Psiq 46:167-171.